By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Puma Biotechnology 

10940 Wilshire Boulevard
Suite 600
Los Angeles  Caliornia   90024  U.S.A.
Phone: 310-443-4150 Fax: 310-443-4158


SEARCH JOBS








Company News
Puma Biotech (PBYI) Submits New Drug Application For PB272 (Neratinib) To U.S. FDA For Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer 7/22/2016 9:18:01 AM
Puma Biotech (PBYI) Announces Interim 5-Year Disease Free Survival Data From Phase III Trial Of PB272 (Neratinib) In Extended Adjuvant HER2-Positive Early Stage Breast Cancer (Extenet Trial) 7/22/2016 9:16:27 AM
Puma Biotech (PBYI) Announces I-SPY 2 Phase II Study Of Neratinib Published In The New England Journal of Medicine 7/7/2016 10:51:30 AM
Puma Biotech (PBYI) Submits Marketing Authorization Application For PB272 (Neratinib) As Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer In Europe 6/27/2016 10:07:05 AM
ASCO2016: Puma Biotech (PBYI) Presents Positive Phase II Data At The 2016 ASCO Annual Meeting 6/6/2016 1:39:46 PM
Puma Biotech (PBYI) Announces Publication Of Neratinib Abstract For The 2016 ASCO Annual Meeting 5/19/2016 11:53:17 AM
Puma Biotech (PBYI) To Present At UBS Global Healthcare Conference 5/17/2016 11:14:01 AM
Puma Biotech (PBYI) Reports First Quarter 2016 Financial Results 5/11/2016 10:05:32 AM
Puma Biotech (PBYI) To Present At Bank of America (BAC) Merrill Lynch Health Care Conference 5/4/2016 10:59:19 AM
Puma Biotech (PBYI)’s Nefert-T Phase II Study Published Online In JAMA Oncology 4/14/2016 10:45:08 AM
12345678910...
//-->